Understanding the Confusion Around Drug Names

Drugs and their names are just confusing. When they are being developed they are given many different names. Despite their names the drugs (or treatments) are the same. Names are just names nothing more. For laymen, drugs having multiple names for the same drug is confusing. So, why are there so many different names for the same drug? Let me try and straighten out the confusion. Usually drugs, as they go through the development process, are given three different names; A chemical name that relates to its molecular composition. This chemical name is usually to long and complex to use [...]

By | December 15th, 2016|Drugs & Treatments, FDA, Uncategorized|0 Comments

The House Passes The 21st Century Cures Act – On To The Senate

Last Wednesday the House passed with a vote of 392 to 26, a medical innovation bill known as the 21st Century Cures Act, aimed at curing diseases, with the measure securing bipartisan support after months of negotiations. The bill’s goals are to speed up the Food and Drug Administration’s approval of new drugs while also investing new money in medical research. The package also includes a range of other healthcare priorities, including $1 billion over two years to fight the epidemic of opioid addiction and $1.8 billion for Vice President Biden’s cancer “moonshot.” The cures legislation also includes a mental health [...]

By | December 1st, 2016|Cancer Moon Shot, FDA, Politics of Cancer, Research, Uncategorized|0 Comments

Caution – The FDA Has Limited The Usage of Nizoral (ketoconazole)

Nizoral (ketoconazole, keto) is an older drug that has been used as a part of hormone therapy (ADT) for many years.  Keto, which is an inexpensive anti-fungal drug had been used for many years as an inhibitor of adrenal androgen synthesis as is abiriterone (Zytiga). Ztiga has been shown to be more effective, however, it is occasionally considered for treatment of metastatic prostate cancer in situations where a man can not afford Zytiga or it is unavailable.  The use of Keto in this manner is totally "off label." If you decided to try this route you need to also be [...]

By | May 4th, 2016|Drugs & Treatments, FDA, ketoconazole, Uncategorized|1 Comment

U.S. Congress Passes Omnibus Funding with Significant Increases for Medical Research

We have some good news, the United States Congress has passed the Omnibus spending package.  The package will fund the U.S. Government through fiscal 2016.  We should take note that this bill includes a $2 billion increase for the National Institute of Health (NIH), a 5% increase for the National Cancer Institute (NCI) and the Food and Drug Administration (FDA).  The bill also includes funding for the Department of Defense Medical Research Program with an allocation of $80 million for the Prostate Cancer Research Program. My only disappointment is that the DOD PCRP (Prostate Cancer Research Program) didn't receive additional [...]

By | December 20th, 2015|advocacy, DOD PCRP, FDA, NCI, NIH, Politics of Cancer, Uncategorized, United States|0 Comments